1. Abbritti G, De Matteis F (1971) Decreased levels of cytochrome P-450 and catalase in hepatic porphyria caused by substituted acetamides and barbiturates. Importance of the allyl group in the molecule of the active drugs. Chem Biol Interact 4: 281–286
2. Brady AM, Lock EA (1990) Induction of porphyria in primary mouse and rat hepatocyte cultures. Toxicologist 10 [1]: 296
3. Cole SPC, Massey TE, Marks GS, Racz WJ (1981a) Effects of porphyrin-inducing drugs on ferrochelatase activity in isolated mouse hepatocytes. Can J Physiol Pharmacol 59: 1155–1158
4. Cole SPC, Whitney RA, Marks GS (1981b) Ferrochelatase-inhibitory and porphyrin-inducing properties of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells. Mol Pharmacol 20: 295–403
5. Cole SPC, Zelt DT, Marks GS (1981c) Comparison of the effects of griseofulvin and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity in chick embryo liver. Mol Pharmacol 19: 477–480